Insights On Pharmaceutical Production

  1. Orally-Disintegrating Dosage Forms With Taste Masked Multiparticulates 7/17/2024

    Learn more about our orally disintegrating tablet (ODT) capabilities and how these innovative technologies have the potential to improve acceptance, adherence, and compliance in pharmacotherapy.

  2. The Evolution Of Parenteral Manufacturing For Sensitive Drugs 3/23/2026

    Parenteral manufacturing is advancing with better facilities, single‑use systems, continuous processing, and Annex 1 compliance to meet demand for specialised biologics and personalised therapies.

  3. OligoPilot™ Oligonucleotide Synthesizer Product Overview 2/3/2025

    Meet our OligoPilot™ oligonucleotide synthesizer – the next generation oligo synthesizer with scales to 150 mmol.

  4. Generate Stable High-Producing Clones In 14 Weeks 6/18/2026

    Rising complexity is putting pressure on cell line development. Discover a streamlined approach that enables rapid generation of stable clones with strong titers and long-term consistency.

  5. Scale With Confidence From Bench To Commercial Production 3/30/2026

    Consistent vessel design, sparging, and bag materials across 1L to 5,000L volumes enable predictable bioreactor scale-up from development through commercial manufacturing.

  6. Advanced Affinity Chromatography Tools For Bispecific Antibody Purification 5/7/2025

    The purification of bispecific antibodies requires specialized tools to remove challenging impurities. Examine effective affinity chromatography techniques that improve the isolation of the desired antibody.

  7. Rapid Selection Of High-Performance CHO Basal And Feed Media 5/5/2026

    A CHO-S bispecific antibody program needed a better basal and feed media combination. Learn how the screening of 180 conditions in 12 weeks identified one that delivered 38% higher titers.

  8. Streamline Bioprocesses While Meeting The Demands Of Modern Cell Culture 12/13/2024

    Xcellerex™ X-platform bioreactors offer modular, user-friendly designs with optimized scalability, adaptable automation, and standardization, enhancing productivity in pilot and cGMP cell culture operations.

  9. Leveraging Integrated Electronic Laboratory Notebook And Inventory Systems 6/15/2026

    Integrating lab notebooks with inventory and asset tracking boosts accuracy and traceability. Real-time visibility cuts errors, speeds decisions, and supports compliant, scalable pharma development.

  10. Combining Patient Centricity And Commercial Viability In Pediatric Product Development 8/15/2024

    Medication acceptance and adherence are critical concerns in pediatric populations due to these patients’ rapid anatomical and physiological development.